Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope
|ClinicalTrials.gov Identifier: NCT00004479|
Recruitment Status : Completed
First Posted : October 19, 1999
Last Update Posted : June 24, 2005
Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
|Condition or disease||Intervention/treatment|
PROTOCOL OUTLINE: This is a randomized, double-blind, crossover, placebo-controlled study.
On day one, patients receive either midodrine or placebo. On day three, patients receive the opposite drug.
|Study Type :||Interventional (Clinical Trial)|
|Study Start Date :||March 1999|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004479
|United States, New York|
|Mount Sinai School of Medicine|
|New York, New York, United States, 10029|
|Study Chair:||Horacio Kaufmann||Icahn School of Medicine at Mount Sinai|